This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Non-small cell lung cancer, adenocarcinoma, helper endpoint
HLP_C3_NSCLC_ADENO
No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
2885 |
4. Check minimum number of eventsNone |
2885 |
5. Include endpointsNone |
2885 |
6. Filter based on genotype QC (FinnGen only) |
2591 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Non-small cell lung cancer, adenocarcinoma, helper endpoint
based on the number of shared cases.
Similar with more cases:
- Non-small cell lung cancer, adenocarcinoma
- Non-small cell lung cancer
- Non-small cell lung cancer, including Hilmo
- Malignant neoplasm of bronchus and lung
- Malignant neoplasm of bronchus and lung, including Hilmo
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2591 | 1029 | 1562 |
| Unadjusted period prevalence (%) | 0.58 | 0.37 | 0.72 |
| Median age at first event (years) | 70.92 | 69.88 | 71.60 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 2698
- Matched controls
- 26980
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
WF004
NOMESCO Finland
Palliative radiotherapy
11.9
315.2
338
322
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
7.4
314.5
514
832
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
28.2
307.7
322
129
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
279.2
307.7
482
21
8140/3-C34.3
ICD-O-3
Adenocarcinoma, NOS, of lower lobe, lung
+∞
307.7
595
*
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
22.6
307.7
253
123
H02AB02
ATC
dexamethasone; systemic
9.0
307.7
1132
2011
UGC12
NOMESCO Finland
Flexible bronchoscopy
11.2
307.7
1073
1505
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
80.5
307.7
521
80
A03FA01
ATC
metoclopramide; systemic, rectal
5.8
307.7
1361
4020
Z51.5
ICD-10 Finland
Palliative care
5.8
307.7
844
1957
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
17.5
307.7
1608
2095
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
33.7
307.7
433
152
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
37.6
307.7
666
233
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
34.3
307.7
289
94
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
25.5
307.7
865
491
GDC00
NOMESCO Finland
Lobectomy of lung
48.0
307.7
249
57
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
17.6
307.7
392
258
L01CA04
ATC
vinorelbine; systemic
41.5
307.7
329
90
130
Kela drug reimbursment
Malignant tumour
20.5
307.7
1592
1769
WF049
NOMESCO Finland
Radiotherapy of metastasis
12.8
307.7
580
564
8140/3-C34.1
ICD-O-3
Adenocarcinoma, NOS, of upper lobe, lung
+∞
307.7
973
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
22.2
307.7
255
126
A04AA01
ATC
ondansetron; systemic, rectal
7.4
307.7
716
1256
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
230.5
307.7
750
45
8140/3-C34.9
ICD-O-3
Adenocarcinoma, NOS, of lung, NOS
+∞
307.7
1005
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
54.0
307.7
664
162
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
298.3
307.7
1225
75
R84
ICPC
Malignant neoplasm bronchus/lung
51.3
307.7
191
40
N02AA05
ATC
oxycodone; systemic
4.4
302.2
1214
4269
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
19.4
298.4
238
134
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
435.4
280.0
276
7
GD1AD
NOMESCO Finland
Thorax CT examination
5.9
259.6
537
1090
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
24.6
257.1
184
80
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
13.4
254.7
248
202
191
Kela drug reimbursment
Erlotinib
102.8
228.3
118
12
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
22.3
220.8
164
78
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.5
214.2
382
667
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.9
213.3
354
574
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
18.9
211.3
169
95
JN4BD
NOMESCO Finland
Extensive body CT
4.3
210.8
686
2002
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
10.2
210.4
247
265
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
6.7
208.1
360
609
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.9
201.4
755
2430
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
3.9
188.1
707
2269
GDB21
NOMESCO Finland
Thoracoscopic segmental resection of lung
56.3
182.3
103
19
L01XE03
ATC
[U] erlotinib
81.7
163.5
87
11
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
28.3
156.7
106
39
TGD00
NOMESCO Finland
Needle biopsy of lung
23.2
147.0
107
48
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
7.2
146.5
227
339
WF002
NOMESCO Finland
Radical radiotherapy
4.4
145.6
407
1041
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.9
144.9
1848
11509
A04AA55
ATC
palonosetron, combinations; systemic
6.8
139.9
231
369
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
19.9
137.7
107
56
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
5.5
137.3
285
568
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
5.2
136.0
300
631
155
Kela drug reimbursment
Afatinib and gefitinib
287.3
134.6
136
5
JN4AD
NOMESCO Finland
Body CT examination
3.2
132.4
646
2397
C34.22
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung adenocarcinoma
204.5
132.0
136
7
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
11.1
130.8
141
133
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.9
130.1
860
3780
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
18.2
129.8
105
60
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
26.4
125.8
87
34
J93.8
ICD-10 Finland
Other pneumothorax
19.7
124.5
97
51
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
44.1
122.6
73
17
GD2AT
NOMESCO Finland
Cytology of the lungs with ultrasound guidance
45.5
120.1
71
16
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
4.1
118.3
357
961
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
20.9
117.3
89
44
WZC30
NOMESCO Finland
Teaching
2.9
117.2
735
3118
R03BB04
ATC
tiotropium bromide; inhalant
3.1
111.9
578
2197
XX3DW
NOMESCO Finland
Time consuming IT work
3.1
110.7
546
2020
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
6.2
109.8
197
341
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.2
109.7
196
338
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
6.9
109.6
176
272
TGA30
NOMESCO Finland
Thoracocentesis
12.4
109.3
109
91
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
20.8
106.8
81
40
GD2CT
NOMESCO Finland
Cytology of the lungs with CT guidance
48.8
106.5
62
13
ZX050
NOMESCO Finland
Stereotactic radiotherapy
11.7
104.9
109
97
1BA04, ,
NOMESCO Finland
357.3
103.9
104
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
16.1
103.8
89
57
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.4
101.0
1149
6404
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
5.3
100.8
213
429
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.1
100.6
301
802
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
18.7
100.5
80
44
A06AH03
ATC
naloxegol; oral
7.9
100.3
140
185
3004
Kela drug reimbursment
Osimertinib
506.0
99.1
98
*
1519, ,
Kela drug reimbursment
484.5
95.0
94
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
17.1
93.7
78
47
J94.8
ICD-10 Finland
Other specified pleural conditions
6.6
93.1
154
245
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
15.2
91.5
81
55
L01EB04
ATC
osimertinib; oral
320.1
91.4
92
*
A04AA02
ATC
granisetron; systemic, transdermal
3.6
90.4
334
1027
N02AA01
ATC
morphine; systemic, rectal
5.7
89.9
174
323
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
23.9
87.8
63
27
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
7.4
87.2
129
182
GA4AT
NOMESCO Finland
Cathetrisation of pleural cavity with ultrasound guidance
7.4
86.3
127
178
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.8
86.0
286
819
8140/3-C34.2
ICD-O-3
Adenocarcinoma, NOS, of middle lobe, lung
+∞
85.9
82
*
WX250
NOMESCO Finland
Intercostal blockade
25.5
85.8
60
24
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
10.2
85.6
97
98
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
18.5
81.3
65
36
C34.02
ICD-10 Finland
Malignant tumor of the main bronchial adenocarcinoma
282.9
81.0
82
*
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
33.1
80.9
52
16
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.2
79.6
359
1246
B01AB05
ATC
enoxaparin; parenteral
2.1
77.4
1118
6687
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
34.9
75.8
48
14
341
Kela drug reimbursment
Afatinib and gefitinib
382.8
75.1
75
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
3.4
74.3
299
967
WZC00
NOMESCO Finland
Treatment plan or consultation
2.1
69.7
1134
7019
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
11.0
68.9
74
69
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
17.1
68.7
57
34
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
4.6
68.1
168
384
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.0
66.6
322
1158
L01XE13
ATC
[U] afatinib
232.4
66.5
68
*
ZX120
NOMESCO Finland
Intravenous
2.7
65.8
398
1614
GAA96
NOMESCO Finland
Other open or percutaneous drainage of pleural cavity
14.2
65.7
60
43
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
8.8
65.6
83
97
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
5.5
64.5
127
239
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
16.7
64.3
54
33
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
16.0
64.2
55
35
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.0
63.3
141
296
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
62.6
838
4787
J01MA14
ATC
moxifloxacin; systemic
2.7
62.6
374
1506
WX892
NOMESCO Finland
Monitored bed care
2.8
62.4
342
1316
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
61.8
531
2536
H02AB06
ATC
prednisolone; systemic
1.9
61.4
1462
10189
R4110
NOMESCO Finland
Physiotherapy
2.0
61.4
917
5446
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
3.9
59.7
186
506
N07BA03
ATC
varenicline; oral
4.2
58.8
165
416
XG410
NOMESCO Finland
Flow-volume spirometry
3.6
55.6
194
570
B03BA03
ATC
hydroxocobalamin; parenteral
2.9
54.9
288
1080
A04AD12
ATC
aprepitant; systemic
5.5
53.9
106
199
J93.9
ICD-10 Finland
Pneumothorax, unspecified
12.6
53.0
52
42
M05BX04
ATC
denosumab; parenteral
2.8
52.6
292
1127
A79
ICPC
Malignancy NOS
5.1
52.6
112
226
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
5.2
51.8
108
214
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.0
51.6
238
830
WW200, ,
SPAT
0.4
50.1
265
5986
B01AB04
ATC
dalteparin; parenteral
3.1
49.6
219
744
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
4.6
49.5
121
274
N03AX16
ATC
[U] pregabalin
2.0
49.5
726
4227
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
13.7
49.4
46
34
GEA00
NOMESCO Finland
Mediastinoscopy
14.4
48.5
44
31
ZX090
NOMESCO Finland
Other technic of radiotherapy
3.9
48.2
148
398
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
6.3
47.7
81
132
FB1AD
NOMESCO Finland
CT examination of arteria pulmonalis
4.1
46.2
132
337
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.7
46.1
260
1010
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
9.3
45.8
55
60
JN4CD
NOMESCO Finland
Very extensive body CT
3.2
45.3
187
610
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
8.6
45.1
58
69
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.0
44.7
207
722
J01MA12
ATC
levofloxacin; systemic
2.0
44.7
663
3855
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.0
44.4
212
753
L01XE02
ATC
[U] gefitinib
228.7
44.1
45
*
GD1CD
NOMESCO Finland
Thorax extensive CT-examination
6.7
43.8
70
107
B01AB10
ATC
tinzaparin; parenteral
2.3
43.7
396
1913
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
7.2
43.7
65
92
Z2446
NOMESCO Finland
Social worker
2.9
43.5
220
806
L03AA13
ATC
pegfilgrastim; parenteral
3.2
43.4
180
589
3001
Kela drug reimbursment
Alectinib
+∞
42.8
41
*
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.2
42.8
176
573
JN4KR
NOMESCO Finland
Whole body very extensive metabolic PET with CT
8.1
41.9
56
70
1504
Kela drug reimbursment
Alectinib
+∞
41.8
40
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
6.1
41.5
72
120
1CD01, ,
NOMESCO Finland
13.3
40.0
38
29
GAC00
NOMESCO Finland
Biopsy of pleura
9.7
39.5
46
48
L01EB03
ATC
afatinib; oral
393.1
39.2
39
*
N02AX02
ATC
tramadol; systemic, rectal
1.7
38.7
1270
9271
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.4
38.5
221
4917
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
13.5
38.3
36
27
L01ED03
ATC
alectinib; oral
+∞
37.6
36
*
R04.2
ICD-10 Finland
Haemoptysis
3.0
35.8
170
601
TPH04
NOMESCO Finland
Cathetrisation of vein
1.8
35.1
702
4438
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.5
35.0
239
1017
GD1BA
NOMESCO Finland
Extensive X-ray examination of thorax
5.1
34.9
73
145
TGC00
NOMESCO Finland
Bronchial lavation
3.5
34.8
122
359
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
6.9
34.4
53
78
A98
ICPC
Health maint/preventive medicine
0.6
34.0
1980
22376
1623C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,ADENOCARCINOMA]
177.2
33.8
35
*
R03AC02
ATC
salbutamol; inhalant
1.6
33.2
1376
10512
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
12.9
33.2
32
25
169
Kela drug reimbursment
Crizotinib
+∞
32.4
31
*
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
4.7
32.3
75
163
WPA10
NOMESCO Finland
Proactive palliative care treatment plan
5.8
31.6
58
102
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
5.2
30.9
64
126
R03AL03
ATC
vilanterol and umeclidinium bromide; inhalant
4.3
30.6
79
187
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
30.0
537
3267
R06.0
ICD-10 Finland
Dyspnoea
1.6
29.3
854
5931
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
3.4
29.2
109
334
Z3231
NOMESCO Finland
Registered nurse
1.7
29.1
784
5335
GDC10
NOMESCO Finland
Bilobectomy of lung
81.0
28.8
32
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.4
27.9
70
162
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.3
27.8
220
998
JN5KR
NOMESCO Finland
Very extensive PET-CT of upper body metabolism (eyebrows to thighs)
10.1
27.4
31
31
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
27.4
349
1900
D70.82
ICD-10 Finland
Drug-induced neutropenia
4.2
26.5
71
173
Z2221
NOMESCO Finland
Medical doctor
1.6
26.3
706
4778
8140/3-C34.0
ICD-O-3
Adenocarcinoma, NOS, of main bronchus
+∞
26.1
25
*
A02BC02
ATC
pantoprazole; systemic
1.6
25.9
1862
15755
ZXD10
NOMESCO Finland
Scheduled procedure
1.6
25.7
1027
7628
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
7.3
25.5
37
51
GAB10
NOMESCO Finland
Antero- or postero-lateral thoracotomy
7.4
25.0
36
49
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
9.8
25.0
29
30
L01EB01
ATC
gefitinib; oral
252.5
24.7
25
*
Z3226
NOMESCO Finland
Physiotherapist
1.7
24.1
514
3267
L01XE16
ATC
[U] crizotinib
+∞
24.0
23
*
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
3.8
23.7
73
197
J43.9
ICD-10 Finland
Emphysema, unspecified
3.4
23.6
86
260
GAA31
NOMESCO Finland
Thoracoscopy
9.4
23.5
28
30
ZXE10
NOMESCO Finland
More than one and less than three hours
1.5
23.3
975
7277
EB1VA, ,
NOMESCO Finland
0.4
23.1
102
2603
N05CF01
ATC
zopiclone; oral
1.5
23.0
926
6850
L01XE35
ATC
[U] osimertinib
231.9
22.6
23
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.8
22.5
403
2435
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
8.4
22.3
29
35
8140/3-C34.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of lung
+∞
21.9
21
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.9
21.8
101
352
WW500
NOMESCO Finland
Blood transfusion
2.5
21.8
146
614
J86.9
ICD-10 Finland
Pyothorax without fistula
4.5
21.7
53
120
GDD00
NOMESCO Finland
Pneumonectomy
39.0
21.7
27
7
WX600
NOMESCO Finland
Single shot through catheter
4.8
21.5
48
101
OAB42, ,
SPAT
0.3
21.3
69
2048
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.2
21.1
189
901
N03AX14
ATC
levetiracetam; systemic
2.9
20.9
100
355
GDC11
NOMESCO Finland
Thoracoscopic bilobectomy of lung
+∞
20.9
20
*
P20
ICPC
Memory disturbance
0.5
20.8
185
3585
TPH07
NOMESCO Finland
Cathetrisation of artery
1.8
20.7
375
2269
WZC00, ,
SPAT
0.4
20.6
102
2480
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.0
20.5
223
1144
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.2
20.0
179
852
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
17.4
20.0
31
18
SPAT1109
SPAT
Analgesia with portable analgesic pump
5.3
19.9
40
77
363
Kela drug reimbursment
Crizotinib
+∞
19.8
19
*
R03AK07
ATC
formoterol and budesonide; inhalant
1.6
19.5
471
3076
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.6
19.5
464
3020
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.4
19.3
135
579
C34.13
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary bronchoalveolar carcinoma
46.3
19.2
23
5
Z72.0
ICD-10 Finland
Tobacco use
3.1
18.8
77
250
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
3.2
18.8
74
235
L01XE36
ATC
[U] alectinib
+∞
18.8
18
*
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
28.0
18.7
25
9
GA3AT
NOMESCO Finland
Pleural cytology with ultrasound guidance
6.8
18.7
29
43
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
3.1
18.7
76
246
EB4VA, ,
NOMESCO Finland
0.3
18.7
69
1924
PJD99
NOMESCO Finland
Excision of other lymph nodes
18.8
18.6
28
15
ZXA00
NOMESCO Finland
Right side
1.5
18.6
754
5535
ZX080
NOMESCO Finland
Image guided radiotherapy
3.0
18.6
83
284
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
2.3
18.4
143
643
J94.9
ICD-10 Finland
Pleural condition, unspecified
5.6
18.2
34
61
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
14.4
18.1
30
21
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.4
17.8
1205
9733
ZXE00
NOMESCO Finland
One hour or less
1.5
17.8
958
7423
C80.92
ICD-10 Finland
Malignant tumor without specified localization adenocarcinoma
20.2
17.7
26
13
GDA11
NOMESCO Finland
Thoracoscopic biopsy of lung
7.1
17.4
26
37
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.3
17.2
41
1438
5826
FHL
Lobectomy or bilobectomy
14.9
17.1
28
19
N06DX01
ATC
memantine; oral
0.4
17.0
67
1813
WF099
NOMESCO Finland
Other radiotherapy
5.4
16.8
33
62
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.6
16.7
398
5878
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
15.1
16.6
27
18
R95
ICPC
Chron obstructive pulmonary disease
2.3
16.6
122
536
WPB10
NOMESCO Finland
Making a convalescent care decision
6.0
16.5
29
49
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
2.3
16.3
123
546
C10AA07
ATC
rosuvastatin; oral
0.7
16.3
504
7035
ZX070
NOMESCO Finland
Intensity modified radiotherapy
2.9
16.3
74
256
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
12.8
16.1
28
22
RS221, ,
NOMESCO Finland
3.8
16.1
48
127
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
13.6
16.0
27
20
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
6.2
15.9
27
44
A06AD11
ATC
lactulose; oral
1.6
15.8
487
3354
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
12.3
15.8
28
23
C34.21
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung epidermoid carcinoma
26.4
15.6
21
8
R4110, ,
SPAT
0.5
15.4
121
2469
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.5
15.4
473
3255
SFA20
NOMESCO Finland
Two-surface restoration
0.7
15.4
810
10248
N07BC02
ATC
methadone; systemic
7.0
15.3
23
33
J93.1
ICD-10 Finland
Other spontaneous pneumothorax
4.3
15.3
39
92
N06DA02
ATC
donepezil; oral
0.3
15.3
42
1362
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
4.0
15.0
42
106
R2110
NOMESCO Finland
Giving the first information
2.1
14.9
144
707
325
Kela drug reimbursment
Erlotinib
57.0
14.8
17
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.6
14.7
304
4661
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.6
14.7
338
2171
SFA10
NOMESCO Finland
One-surface restoration
0.7
14.7
779
9868
WX330
NOMESCO Finland
Paravertebral ansthesia
80.6
14.6
16
*
TXQ05
NOMESCO Finland
Puncture of skin, site unspecified
150.8
14.5
15
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
15.4
14.4
23
15
C34.33
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung bronchoalveolar carcinoma
27.3
14.3
19
7
R52.0
ICD-10 Finland
Acute pain
2.5
14.3
89
363
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
2.4
14.2
94
394
R23.8
ICD-10 Finland
Other and unspecified skin changes
0.6
14.2
260
4109
SAA02
NOMESCO Finland
Basic examination of mouth
0.7
14.1
976
11860
WPA15
NOMESCO Finland
Palliative care consultation with the patient and loved ones
5.0
14.0
30
61
SDA03
NOMESCO Finland
Periodontal treatment
0.7
13.9
475
6543
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.7
13.9
450
6265
JN6AD
NOMESCO Finland
CT of torso and neck
2.9
13.9
63
218
R85
ICPC
Malignant neopl respiratory other
10.5
13.7
26
25
GDB10
NOMESCO Finland
Wedge resection of lung
13.6
13.7
23
17
S27.0
ICD-10 Finland
Traumatic pneumothorax
4.3
13.6
34
79
I31.9
ICD-10 Finland
Disease of pericardium, unspecified
4.3
13.6
34
79
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
13.6
384
2590
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
18.3
13.4
20
11
SFA30
NOMESCO Finland
Three-surface restoration
0.7
13.3
581
7652
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
15.1
13.1
21
14
SAA01
NOMESCO Finland
Simple examination of mouth
0.7
13.0
1148
13512
WZC30, ,
SPAT
0.4
12.9
55
1437
GD2FN
NOMESCO Finland
Lung ventilation distribution isotope examination (radiospirometry)
50.2
12.8
15
*
N05BA06
ATC
lorazepam; systemic, sublingual
1.9
12.7
152
807
D38.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pleura
12.3
12.6
22
18
C10AX09
ATC
ezetimibe; oral
0.6
12.6
222
3552
1CD02, ,
NOMESCO Finland
4.1
12.6
34
84
L01ED01
ATC
crizotinib; oral
+∞
12.5
12
*
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
12.3
499
3624
1BC05, ,
NOMESCO Finland
37.7
12.2
15
*
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
2.6
12.2
69
269
M79.6
ICD-10 Finland
Pain in limb
0.7
12.1
669
8497
K02.1
ICD-10 Finland
Caries of dentine
0.7
12.0
843
10314
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
11.9
318
2115
SPAT1053
SPAT
Memory test
0.6
11.8
225
3537
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
2.1
11.8
117
581
OAB44, ,
SPAT
0.4
11.7
54
1364
R03BB01
ATC
ipratropium bromide; inhalant
1.9
11.5
143
768
TQW40, ,
SPAT
0.5
11.5
80
1711
H13
ICPC
Plugged feeling ear
0.6
11.5
289
4265
1625C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,ADENOCARCINOMA]
120.5
11.4
12
*
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
4.1
11.3
30
73
L03AA02
ATC
filgrastim; parenteral
2.2
11.3
90
410
I10
ICD-10 Finland
Essential (primary) hypertension
0.8
11.3
1434
16193
N06DA03
ATC
rivastigmine; oral, transdermal
0.3
11.2
27
942
XX9XW, ,
NOMESCO Finland
4.9
11.2
24
49
YX9AW, ,
NOMESCO Finland
4.5
11.2
27
61
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
4.1
11.1
30
74
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
20.1
11.1
16
8
DAX08
NOMESCO Finland
Fitting of hearing aid
0.4
11.1
47
1231
EBA15
NOMESCO Finland
Extraction of multiple teeth
2.0
11.0
118
603
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
3.8
11.0
33
88
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
4.3
11.0
28
66
A02BC01
ATC
omeprazole; systemic
1.4
11.0
705
5537
C34.23
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung bronchoalveolar carcinoma
43.5
10.9
13
*
ZYC01, ,
SPAT
0.4
10.8
63
1443
QBC00
NOMESCO Finland
Removal of foreign body from skin of trunk or subcutaneous tissue
15.5
10.8
17
11
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
10.8
154
866
TDA90, ,
SPAT
0.4
10.7
52
1282
L17
ICPC
Foot/toe symptom/complaint
0.7
10.7
453
6045
WW200
NOMESCO Finland
Immunization
2.5
10.7
67
275
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.1
10.7
100
487
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.5
10.6
94
1844
L15
ICPC
Knee symptom/complaint
0.7
10.6
327
4632
D82
ICPC
Teeth/gum disease
0.7
10.6
424
5717
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
8.5
10.5
22
26
205
Kela drug reimbursment
Chronic hypertension
0.7
10.5
545
7034
OAA67, ,
SPAT
0.3
10.5
27
907
Z01.2
ICD-10 Finland
Dental examination
0.7
10.5
616
7795
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.7
10.5
594
7557
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.7
10.4
293
4228
ZXE30
NOMESCO Finland
More than five and less than seven hours
1.9
10.4
130
702
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.3
10.3
78
348
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
10.3
569
7275
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
3.3
10.3
37
112
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
10.2
600
4636
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
3.1
10.2
42
138
GA2AT
NOMESCO Finland
Pleural biopsy with ultrasound guidance
13.2
10.1
17
13
WZC15, ,
NOMESCO Finland
3.6
10.1
32
89
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.2
10.0
38
119
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
0.5
10.0
122
2162
F03
ICD-10 Finland
Unspecified dementia
0.3
9.9
27
880
I31.3
ICD-10 Finland
Pericardial effusion (noninflammatory)
7.6
9.9
22
29
ZXD05
NOMESCO Finland
Urgent procedure
1.3
9.9
710
5658
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
9.9
15
687
H25.1
ICD-10 Finland
Senile nuclear cataract
0.7
9.9
595
7514
C39.9
ICD-10 Finland
Malignant neoplasm: Ill-defined sites within the respiratory system
26.1
9.8
13
5
L57.0
ICD-10 Finland
Actinic keratosis
0.6
9.8
148
2473
R03AC19
ATC
olodaterol
4.7
9.8
22
47
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.0
9.7
104
532
A10BK03
ATC
empagliflozin; oral
0.5
9.7
110
1993
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
3.6
9.7
31
87
GDB20
NOMESCO Finland
Segmental resection of lung
55.2
9.6
11
*
XG466
NOMESCO Finland
Sleep oxymetry
2.1
9.6
84
398
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
0.2
9.6
18
723
XF600
NOMESCO Finland
Bloodpressure measurement
1.7
9.6
166
989
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.6
9.4
193
2993
WX402
NOMESCO Finland
General anaesthesia
1.4
9.4
490
3705
GAC01
NOMESCO Finland
Endoscopic biopsy of pleura
7.6
9.4
21
28
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
17.6
9.4
14
8
L01ED05
ATC
lorlatinib; oral
+∞
9.4
9
*
3017
Kela drug reimbursment
Brigatinib
+∞
9.4
9
*
L01EB02
ATC
erlotinib; oral
+∞
9.4
9
*
GX1K5
NOMESCO Finland
Diffusion capacity
4.2
9.4
24
57
K03.64
ICD-10 Finland
Dental calculus supragingival
0.7
9.3
335
4619
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
2.0
9.3
102
527
AXX01, ,
SPAT
0.3
9.3
24
801
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
3.2
9.2
36
115
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.3
9.2
19
720
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
3.6
9.1
29
81
GD6AD
NOMESCO Finland
CT of chest and neck
4.8
9.1
20
42
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.6
8.8
136
2262
DQB10
NOMESCO Finland
Endoscopic excision of lesion of larynx
3.2
8.8
34
108
R03AL04
ATC
indacaterol and glycopyrronium bromide; inhalant
4.1
8.7
23
56
C09CA01
ATC
losartan; oral
0.7
8.6
437
5689
J43.2
ICD-10 Finland
Centrilobular emphysema
4.8
8.6
19
40
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
0.6
8.6
157
2502
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
16.3
8.5
13
8
L03
ICPC
Low back symptom/complaint
0.7
8.5
376
5009
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.7
8.5
317
4350
XX1XW
NOMESCO Finland
Extensive written report from radiologist
2.3
8.4
61
268
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
7.4
8.4
19
26
D35.0
ICD-10 Finland
Benign neoplasm: Adrenal gland
2.6
8.4
47
183
SDA02
NOMESCO Finland
Periodontal treatment, brief
0.7
8.4
460
5920
3026
Kela drug reimbursment
Lorlatinib
+∞
8.3
8
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.8
8.3
744
8934
ZX114
NOMESCO Finland
Intramuscular
3.0
8.2
36
123
WF003
NOMESCO Finland
Adjuvant radiotherapy
2.0
8.2
89
459
NH3AA, ,
SPAT
0.2
8.1
7
372
GD6BD
NOMESCO Finland
Extensive CT of chest and neck
8.1
8.1
17
21
ZXA05
NOMESCO Finland
Left side
1.3
8.1
635
5107
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.5
8.0
244
1666
WZB00, ,
SPAT
0.4
8.0
44
1029
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.7
8.0
270
3778
R4190
NOMESCO Finland
Nutritional therapy
2.0
8.0
83
421
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
1.8
8.0
125
724
N05AX08
ATC
risperidone; systemic
0.5
7.9
79
1492
L13
ICPC
Hip symptom/complaint
0.7
7.9
281
3895
1623X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]
13.1
7.9
13
10
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
7.8
7.9
17
22
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
7.9
891
7511
ZXH06, ,
SPAT
0.3
7.9
24
733
I26.0
ICD-10 Finland
Pulmonary embolism with mention of acute cor pulmonale
2.1
7.8
67
316
A10BK01
ATC
dapagliflozin; oral
0.5
7.8
71
1381
R50.9
ICD-10 Finland
Fever, unspecified
1.4
7.8
364
2697
J98.4
ICD-10 Finland
Other disorders of lung
8.5
7.8
16
19
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.3
7.8
23
713
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
0.4
7.8
50
1097
H02
ICPC
Hearing complaint
0.7
7.7
230
3298
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
3.0
7.7
32
106
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
3.7
7.7
24
66
7931A
ICD-9 Finland
Nonspecific abnormal findings on radiological and other examination of body structure, Lung field
4.2
7.7
20
48
K05.10
ICD-10 Finland
Gingivitis (chronic) NOS
0.6
7.7
118
1968
N40
ICD-10 Finland
Hyperplasia of prostate
0.8
7.7
530
6613
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
2.9
7.7
34
117
G20
ICD-10 Finland
Parkinson disease
0.3
7.7
16
600
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
3.7
7.6
23
62
L08
ICPC
Shoulder symptom/complaint
0.7
7.6
313
4229
B01AF01
ATC
rivaroxaban; oral
0.6
7.6
181
2717
C38.1
ICD-10 Finland
Malignant neoplasm: Anterior mediastinum
25.1
7.6
10
*
N02AA03
ATC
hydromorphone; systemic, rectal
6.2
7.5
19
31
OAB38
NOMESCO Finland
Psychosocial guidance and counselling
6.2
7.5
19
31
JN4DD
NOMESCO Finland
Scout CT scan of torso
10.0
7.5
14
14
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
2.6
7.5
42
164
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
0.6
7.4
123
2009
N05AD01
ATC
haloperidol; systemic
1.9
7.4
87
462
Z96.1
ICD-10 Finland
Presence of intraocular lens
0.7
7.4
243
3417
N05BA04
ATC
oxazepam; oral
1.3
7.3
596
4807
SPAT1312
SPAT
General health counselling
0.7
7.3
445
5656
SDA01
NOMESCO Finland
Periodontal treatment, very brief
0.7
7.3
313
4202
ZX095
NOMESCO Finland
Combined chemoradiotherapy
3.6
7.3
23
64
L01ED04
ATC
brigatinib; oral
+∞
7.3
7
*
GEB40
NOMESCO Finland
Mediastinotomy and extended excision of lesion
+∞
7.3
7
*
1521, ,
Kela drug reimbursment
+∞
7.3
7
*
C79.49
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified parts of nervous system
+∞
7.3
7
*
J86.00
ICD-10 Finland
Empyema with broncho-pleural fistula
9.4
7.3
14
15
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
7.3
161
1025
R02
ICPC
Shortness of breath/dyspnoea
1.4
7.2
348
2591
N04BD01
ATC
selegiline; oral
0.0
7.2
*
213
L82
ICD-10 Finland
Seborrhoeic keratosis
0.7
7.2
268
3690
A04AA03
ATC
tropisetron; systemic
6.2
7.2
18
29
M19.0
ICD-10 Finland
Primary arthrosis of other joints
0.6
7.2
105
1775
110
Kela drug reimbursment
Parkinson's disease and comparable movement disrorders
0.2
7.2
13
530
GA2CT
NOMESCO Finland
Pleural biopsy with CT guidance
30.1
7.1
9
*
GWE00
NOMESCO Finland
Reoperation for deep haemorrhage in thoracic surgery
20.1
7.1
10
5
K86
ICPC
Hypertension uncomplicated
0.7
7.1
200
2902
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
3.5
7.1
24
70
C50.90
ICD-10 Finland
Malignant tumor in other or unspecified location in mammary gland without histology
2.6
7.0
38
146
C08CA13
ATC
lercanidipine; oral
0.7
7.0
215
3067
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.3
7.0
437
3392
G47.3
ICD-10 Finland
Sleep apnoea
0.7
7.0
306
4095
D19
ICPC
Teeth/gum symptom/complaint
0.7
7.0
356
4650
XX2RW, ,
NOMESCO Finland
2.5
6.9
40
159
R03AC18
ATC
indacaterol; inhalant
3.1
6.9
28
92
A07AA02
ATC
nystatin; oral
1.6
6.9
147
928
OAB75, ,
SPAT
0.1
6.8
*
254
OAB43, ,
SPAT
0.5
6.8
74
1359
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
2.8
6.8
33
120
UGB02
NOMESCO Finland
Tracheoscopy
11.0
6.8
12
11
1XC18, ,
NOMESCO Finland
40.2
6.8
8
*
GA3CT
NOMESCO Finland
Pleural cytology with CT guidance
40.2
6.8
8
*
GCA02
NOMESCO Finland
Bronchoscopic electrocoagulation of lesion of bronchus
40.2
6.8
8
*
J17.3*B59
ICD-10 Finland
Pneumonia due to Pneumocystis carinii
4.3
6.7
17
40
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.7
6.7
326
4294
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
2.6
6.7
36
138
J96.1
ICD-10 Finland
Chronic respiratory failure
2.0
6.7
73
378
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
1.7
6.7
117
702
OAB50, ,
SPAT
0.5
6.6
78
1395
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
1.6
6.6
133
828
R03AC13
ATC
formoterol; inhalant
1.7
6.6
122
743
NG1AA, ,
SPAT
0.4
6.6
29
740
NJ2MA
NOMESCO Finland
Measurement of mechanical axis of lower leg with X-ray
0.5
6.5
67
1252
GAC97
NOMESCO Finland
Other endoscopic operation on pleura
6.8
6.5
15
22
J01AA02
ATC
doxycycline; systemic
1.3
6.5
1907
17747
Z25.8
ICD-10 Finland
Need for immunization against other specified single viral diseases
0.6
6.5
86
1490
PJ2AE
NOMESCO Finland
Lymphnode ultrasound examination
3.0
6.5
27
90
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.7
6.5
116
700
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
3.7
6.5
20
55
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
2.4
6.5
42
177
G30.8
ICD-10 Finland
Other Alzheimer disease
0.3
6.4
13
495
1240
FHL
Bronchoscopy
2.5
6.4
38
153
1629C
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,ADENOCARCINOMA]
70.0
6.4
7
*
Z00.0
ICD-10 Finland
General medical examination
0.7
6.4
263
3559
T90
ICPC
Diabetes non-insulin dependent
0.8
6.4
440
5508
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
6.6
6.3
15
23
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.7
6.3
339
4401
J92.0
ICD-10 Finland
Pleural plaque with presence of asbestos
1.9
6.3
71
372
G04BD12
ATC
mirabegron; oral
0.7
6.3
177
2570
ZX109
NOMESCO Finland
Instruction on medicine inhalation technique
2.9
6.3
28
97
8000/3-C34.9
ICD-O-3
Neoplasm, malignant of lung, NOS
0.0
6.3
*
160
6350C
ICD-9 Finland
Legally induced abortion, Complicated by genital tract and pelvic infection[ABORTUS PROV LEGAL SINE COMPL,SOSIAALISET SYYT]
2.2
6.3
51
237
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
2.2
6.3
49
224
J91
ICD-10 Finland
Pleural effusion in conditions classified elsewhere
7.0
6.2
14
20
R05
ICD-10 Finland
Cough
1.3
6.2
469
3737
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
0.6
6.2
104
1693
G04CB02
ATC
dutasteride; oral
0.6
6.2
129
1995
SPAT1310
SPAT
Counselling related to known health issue
0.8
6.2
497
6102
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
3.1
6.2
24
77
WPA13
NOMESCO Finland
Palliative consultation
3.5
6.2
20
57
M04AA01
ATC
allopurinol; systemic
0.7
6.1
233
3199
SPAT1249
SPAT
Treatment-related counselling outside office
0.8
6.1
635
7559
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
2.1
6.1
53
253
XW4AT
NOMESCO Finland
Biopsy of other inner organ with ultrasound guidance
4.1
6.1
16
39
XG460
NOMESCO Finland
Short time oxymetry
2.2
6.1
49
227
L03AA14
ATC
lipegfilgrastim; parenteral
2.3
6.1
44
195
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.7
6.0
189
2687
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
0.8
6.0
475
5851
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
3.1
6.0
24
78
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
6.7
6.0
14
21
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.1
6.0
51
241
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
444
379
13.83
307.65
1.6
1.9
16.28
25.76
ug/l
1.95
439
372
179
10
191.65
307.65
1.1
1.1
—
—
—
0
0
494
343
17.41
307.65
1.2
1.1
—
—
—
0
0
513
639
9.68
307.65
1.4
1.5
—
—
—
0
0
533
1052
6.07
265.84
2.1
2.7
—
—
—
0
0
944
3090
4.16
252.39
4.3
4.2
103.27
20.35
ug/l
3.32
869
2573
353
482
8.28
249.33
1.4
1.5
38.89
31.07
g/l
21.34
335
431
314
423
8.27
223.74
1.5
1.4
2516.86
3975.50
e6/l
0.30
226
286
256
269
10.41
221.54
1.5
1.5
25.48
31.03
ng/l
0.47
256
269
290
374
8.57
214.11
1.4
1.4
66771.49
80536.41
e6/l
0.20
176
211
251
319
8.57
187.09
1.3
1.4
797.29
321.02
u/l
3.08
244
302
1051
4546
3.15
171.30
4.5
3.2
0.79
0.82
mmol/l
7.71
1021
4264
239
336
7.71
163.14
1.3
1.4
5.78
6.42
mmol/l
1.70
224
315
204
257
8.51
152.69
1.2
1.3
12.24
14.00
u/l
0.39
196
233
605
2148
3.34
133.49
5.5
2.2
419.43
376.81
nmol/l
4.66
590
1961
279
580
5.25
128.00
1.3
1.3
—
—
—
0
0
810
3553
2.83
121.81
4.4
4.3
253.19
245.95
u/l
0.58
795
3347
522
1858
3.24
113.21
1.5
1.4
—
—
—
0
0
167
239
7.38
111.64
1.3
1.4
10.50
13.51
u/l
7.13
157
227
1692
11167
2.38
99.86
7.9
6.4
2.44
2.85
%
10.50
1661
10377
1704
11322
2.37
98.38
7.9
6.4
22.34
26.01
%
33.84
1679
10644
1927
13535
2.48
97.67
17.1
9.5
4.89
4.28
e9/l
16.90
1706
11628
1671
11104
2.33
95.03
7.7
6.3
62.13
58.52
%
26.16
1648
10531
1750
12012
2.30
89.84
7.8
6.0
0.71
0.62
e9/l
23.37
1498
10101
1751
12060
2.29
88.57
7.8
6.0
0.04
0.04
e9/l
1.53
1503
10145
95
92
10.67
86.32
1.2
1.3
1018.82
113.54
ug/l
2.98
80
38
172
330
5.50
85.74
1.3
1.3
14.22
10.73
u/l
1.78
143
262
1761
12245
2.26
85.73
7.9
6.1
1.81
1.87
e9/l
0.35
1537
10569
837
4304
2.37
85.63
2.3
2.0
29.77
29.84
s
0.13
827
4178
1773
12395
2.26
84.69
8.1
6.2
0.19
0.20
e9/l
0.99
1535
10605
92
92
10.32
81.72
1.2
1.5
4.23
3.29
mmol/l
1.30
87
82
1855
13317
2.26
81.40
12.9
6.9
9.73
12.33
umol/l
18.14
1825
12719
1069
6288
2.16
77.23
6.1
4.3
92.12
84.38
%
24.10
1057
6158
1797
12958
2.16
74.72
12.8
19.0
1.19
1.34
inr
29.60
1493
10921
1702
12137
2.09
71.30
8.8
6.8
1.21
1.21
mmol/l
3.08
1642
11138
129
228
5.89
70.07
1.2
1.3
—
—
—
0
0
1823
13453
2.09
68.03
10.4
7.6
1.21
1.21
mmol/l
0.89
1611
11552
944
5531
2.09
66.70
6.2
3.1
2.51
2.46
mmol/l
24.94
891
4966
1683
20725
0.50
61.17
4.3
5.5
1.41
1.44
mmol/l
1.83
1459
18764
500
9252
0.44
61.12
1.8
2.0
1.36
1.30
mmol/l
1.16
428
7531
1693
20742
0.51
58.78
6.2
7.5
40.14
40.44
mmol/mol
0.69
1486
19055
1714
20908
0.51
58.46
4.3
5.6
4.47
4.41
mmol/l
1.32
1493
19092
67
70
9.79
57.59
1.3
1.4
19.86
24.08
%
0.47
59
53
1785
21366
0.51
53.85
4.9
6.5
2.59
2.52
mmol/l
2.67
1539
19429
408
1836
2.44
53.75
7.7
9.0
24.86
24.19
mmol/l
5.24
400
1797
1606
11865
1.87
53.10
6.9
5.2
32.81
34.75
g/l
30.79
1547
11076
1298
9007
1.85
52.10
6.8
3.6
2.37
2.35
mmol/l
3.49
1242
8086
1623
19905
0.54
50.74
3.8
4.7
1.30
1.27
mmol/l
1.13
1388
17810
1104
7493
1.80
45.86
4.6
3.3
31.96
37.30
u/l
2.06
1071
7035
79
131
6.18
45.73
1.2
1.5
63.57
66.60
%
0.30
69
107
114
266
4.43
44.91
1.4
1.3
32.41
36.28
iu/l
0.50
92
222
621
3533
1.98
44.63
6.9
7.3
1.17
0.95
mmol/l
0.87
539
2878
623
3553
1.98
44.44
6.9
7.4
5.26
5.08
kpa
4.66
595
3406
621
3553
1.97
43.81
6.9
7.4
11.55
11.93
kpa
1.16
592
3409
496
2627
2.09
43.34
6.9
7.3
1.18
1.37
mmol/l
4.99
483
2579
792
4989
1.83
41.16
2.1
2.0
—
—
—
0
0
120
326
3.81
38.50
3.2
3.7
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
250
1042
2.54
38.29
2.4
2.9
0.35
0.34
iu/ml
0.09
131
578
932
6289
1.74
37.59
2.7
2.6
—
—
—
0
0
201
777
2.71
35.80
1.5
1.8
—
—
—
0
0
1357
10223
1.66
35.53
16.8
12.8
0.00
0.00
e9/l
0.27
1056
8276
1827
14878
1.71
35.30
7.6
5.4
6.72
6.87
mmol/l
3.20
1785
14267
424
2324
1.98
32.97
2.8
2.5
32.93
39.12
u/l
1.26
363
1946
1836
21123
0.59
32.95
5.4
5.9
6.14
6.10
mmol/l
0.59
1600
18951
89
225
4.06
31.57
1.4
1.5
—
—
—
0
0
623
9200
0.58
30.20
3.1
3.5
6.83
7.19
mmol/l
1.55
496
7634
600
3770
1.76
30.00
2.0
1.9
—
—
—
0
0
457
2689
1.84
28.31
1.9
2.8
64.17
66.11
g/l
6.30
429
2453
520
3207
1.77
27.46
7.6
7.6
95.01
95.31
%
0.57
501
3089
776
5331
1.64
27.44
5.0
4.3
336.22
558.11
ng/l
0.58
690
4615
646
9288
0.60
27.32
3.9
4.3
13.11
8.96
mg/mmol
1.00
417
5845
558
3517
1.74
27.29
2.0
1.9
—
—
—
0
0
353
1964
1.92
25.88
4.6
3.8
5.16
5.14
kpa
0.16
340
1871
149
602
2.56
24.22
1.5
1.4
—
—
—
0
0
135
523
2.66
23.89
1.5
1.4
—
—
—
0
0
315
1734
1.92
23.76
9.1
9.7
15.79
15.80
%
0.03
306
1668
307
1677
1.94
23.69
4.5
3.6
2.49
1.92
mmol/l
1.81
251
1227
68
175
3.96
23.59
1.1
1.2
—
—
—
0
0
798
10663
0.64
23.23
2.3
2.4
76.61
79.48
nmol/l
1.76
708
9369
471
2956
1.72
23.00
8.2
8.1
120.00
120.10
g/l
0.04
459
2885
30
39
7.77
21.68
1.2
1.4
80.71
73.75
%
0.59
25
31
1759
19944
0.66
21.63
6.5
5.4
1.92
2.04
mu/l
2.42
1574
18006
255
1349
1.98
21.54
1.8
1.9
2.64
2.42
ug/l
0.07
234
1177
134
553
2.50
20.84
1.2
1.4
—
—
—
0
0
134
553
2.50
20.84
1.2
1.4
—
—
—
0
0
160
725
2.28
20.20
1.5
1.6
—
—
—
0
0
123
496
2.55
20.09
1.4
1.6
—
—
—
0
0
114
443
2.64
20.07
1.4
1.4
—
—
—
0
0
37
66
5.67
19.92
1.1
1.2
2.04
1.56
mmol/l
1.67
30
43
158
717
2.28
19.87
1.4
1.5
—
—
—
0
0
1029
7962
1.47
19.76
4.8
2.7
64.59
71.20
u/l
0.27
990
7333
212
1090
2.03
19.37
2.0
2.1
244.49
677.16
ug/l
1.53
194
1034
2101
22830
0.64
18.99
48.0
30.3
125.65
132.74
g/l
86.56
2070
22503
322
1910
1.78
18.96
1.9
1.8
—
—
—
0
0
2101
22828
0.64
18.94
48.9
30.6
38.25
39.66
%
36.84
2064
22484
2101
22827
0.64
18.92
47.7
30.0
91.68
91.93
fl
1.54
2066
22494
2101
22827
0.64
18.92
47.7
30.0
4.23
4.39
e12/l
39.20
2033
22163
2101
22826
0.64
18.90
47.8
30.1
270.47
240.14
e9/l
57.34
2045
22264
2102
22831
0.64
18.82
47.8
30.1
8.08
6.90
e9/l
36.49
2031
22174
613
8390
0.65
18.66
4.4
5.1
20.30
22.12
%
2.56
327
4562
617
4349
1.54
18.36
3.2
3.4
2.00
1.81
e6/l
0.28
311
2231
808
10442
0.68
18.32
5.2
6.2
2.34
4.03
ug/l
3.49
702
9293
153
715
2.21
17.94
2.6
2.3
123.27
128.00
g/l
1.09
86
558
2095
22731
0.65
17.91
42.9
26.8
79.74
84.49
umol/l
8.54
2063
22419
32
55
5.88
17.91
1.3
1.7
14.90
6.33
%
1.10
20
30
122
526
2.38
17.28
1.5
1.4
—
—
—
0
0
961
11948
0.70
17.24
2.1
2.3
91.98
94.04
pmol/l
0.63
492
6320
121
522
2.38
17.12
1.5
1.9
3.65
15.63
iu/l
0.50
16
196
959
7527
1.43
16.20
3.5
3.6
0.52
0.45
e6/l
0.40
712
5684
147
718
2.11
15.42
3.8
3.5
2.35
1.94
index
0.42
92
367
2070
22393
0.68
15.40
23.1
13.6
24.72
25.19
u/l
0.60
2036
21567
2035
18322
1.45
14.90
18.2
8.7
90.53
82.17
u/l
6.48
2007
17326
28
51
5.54
14.77
1.2
1.3
94.17
733.38
u/l
0.49
23
34
109
485
2.30
14.41
2.1
3.9
1.73
1.69
%
0.04
102
427
2092
22514
0.68
14.02
37.1
24.6
4.01
4.01
mmol/l
0.42
2054
22026
2092
22486
0.69
13.51
36.8
24.3
138.37
139.64
mmol/l
62.89
2060
22032
86
355
2.47
13.46
1.5
1.6
—
—
—
0
0
731
9232
0.71
13.03
4.0
4.3
0.01
0.09
estimate
0.92
210
2221
121
592
2.09
12.68
4.8
4.9
3.08
2.65
mmol/l
0.73
94
410
86
366
2.39
12.61
1.6
1.6
—
—
—
0
0
312
2042
1.60
12.49
1.5
1.7
—
—
—
0
0
1061
8759
1.35
12.22
3.5
3.7
46.48
91.26
e6/l
2.23
807
6839
646
8238
0.72
11.92
1.7
1.8
19.70
20.08
nmol/l
0.28
567
6857
620
4721
1.41
11.72
3.1
3.3
1.08
1.06
e6/l
0.05
316
2621
27
59
4.61
11.65
1.1
1.2
0.31
2.90
mmol/l
1.43
22
39
651
5004
1.40
11.63
1.8
1.7
2.13
1.56
mg/l
1.65
558
3975
1321
11317
1.33
11.61
3.1
3.0
—
—
estimate
—
0
0
559
7260
0.71
11.39
4.0
4.4
0.00
0.00
estimate
0.78
211
2429
414
5665
0.68
11.32
1.6
1.8
485.93
23275540.05
pmol/l
3.45
322
4580
34
91
3.77
11.29
1.1
1.4
—
—
—
0
0
189
1115
1.75
11.26
2.9
3.4
702.16
4704.75
u/ml
0.93
166
961
406
5555
0.68
11.05
4.1
4.5
1.02
1.02
kg/l
0.01
307
3780
53
193
2.78
10.72
1.6
1.4
—
—
—
0
0
34
95
3.61
10.63
1.1
1.7
—
—
—
0
0
34
95
3.61
10.63
1.1
1.7
—
—
—
0
0
67
276
2.46
10.60
1.3
1.6
—
—
—
0
0
233
1479
1.63
10.55
1.5
1.5
—
—
—
0
0
101
496
2.08
10.53
3.7
5.1
421.62
3734.64
iu/ml
0.53
13
70
1480
16565
0.76
10.43
5.5
4.3
15.39
15.08
pmol/l
4.16
1352
14843
20
37
5.44
10.40
1.2
1.2
—
—
—
0
0
64
261
2.49
10.35
1.3
1.6
—
—
—
0
0
34
97
3.54
10.32
1.1
1.7
—
—
—
0
0
1129
9575
1.31
10.20
4.2
4.3
70.22
116.25
e6/l
1.78
819
7048
49
178
2.79
9.97
1.7
1.4
—
—
—
0
0
170
1016
1.72
9.69
5.4
4.0
25.60
24.80
mmol/l
2.45
163
930
47
170
2.80
9.65
1.7
1.5
—
—
—
0
0
1931
20755
0.76
9.32
34.2
19.9
76.62
73.07
ml/min/173m2
13.38
1847
19479
1089
12557
0.78
9.03
3.8
4.3
0.00
2.94
estimate
1.59
248
2797
57
236
2.45
8.97
1.3
1.5
—
—
—
0
0
57
236
2.45
8.97
1.3
1.5
—
—
—
0
0
57
236
2.45
8.97
1.3
1.5
—
—
—
0
0
179
1111
1.65
8.87
1.9
2.0
—
—
—
0
0
1101
12660
0.78
8.85
3.9
4.3
0.00
0.13
estimate
0.60
232
2599
111
602
1.88
8.77
1.4
1.6
—
—
—
0
0
126
2133
0.57
8.72
1.4
1.4
—
—
—
0
0
1078
12405
0.78
8.63
3.8
4.2
0.00
0.00
estimate
0.50
248
2719
112
616
1.85
8.48
2.1
2.3
225.31
205.74
%
1.58
106
582
20
45
4.47
8.36
1.1
1.2
—
—
—
0
0
475
6073
0.74
8.26
3.4
3.6
0.79
0.82
ug/l
0.37
344
4375
59
259
2.31
8.19
4.5
3.4
14.65
10.64
index
3.02
46
142
384
2856
1.40
8.07
2.8
2.8
8.11
9.33
umol/l
0.40
338
2573
337
4490
0.71
7.53
1.2
1.3
2.81
1.52
u/ml
0.68
68
1119
218
3139
0.67
7.48
10.0
7.8
—
—
—
0
0
54
241
2.27
7.25
1.6
1.6
—
—
—
0
0
36
133
2.73
7.18
1.1
1.6
—
—
—
0
0
36
133
2.73
7.18
1.1
1.6
—
—
—
0
0
36
133
2.73
7.18
1.1
1.6
—
—
—
0
0
36
133
2.73
7.18
1.1
1.6
—
—
—
0
0
87
470
1.88
7.02
1.8
1.9
1.65
1.69
mmol/l
0.14
87
455
970
8353
1.25
6.95
2.6
2.2
140.38
225.91
u/l
5.76
941
7878
66
325
2.06
6.95
2.2
3.9
58.86
58.27
%
0.08
61
277
146
947
1.57
6.12
2.1
4.2
81.45
84.69
u/ml
0.04
140
912
155
1026
1.54
5.95
1.7
1.9
—
—
—
0
0
16
31
5.19
5.69
1.1
1.0
42.33
13.75
iu/ml
—
6
12
293
3795
0.74
5.33
1.3
1.3
35.93
37.48
iu/ml
0.08
107
1170
373
2941
1.31
5.30
3.2
3.6
2.07
1.86
mmol/l
0.48
328
2536
517
4262
1.26
5.18
2.3
2.7
20.04
21.95
%
1.85
495
3962
289
2215
1.34
5.01
6.1
4.1
1.22
1.22
mmol/l
0.00
276
1918
565
6684
0.80
4.95
2.7
3.0
350.45
358.97
umol/l
1.00
483
5742
1548
16651
0.84
4.95
42.9
26.4
328.33
331.33
g/l
32.25
1531
16536
22
77
2.87
4.92
1.2
1.8
1.75
1.68
ratio
0.08
22
71
463
3790
1.27
4.91
4.4
5.8
1.03
1.04
mmol/l
0.30
440
3520
37
170
2.19
4.75
2.8
3.7
—
—
—
0
0
905
10183
0.83
4.73
3.0
3.1
237.57
157.54
ug/l
6.28
831
9291
35
158
2.23
4.69
1.2
1.2
236.67
117.78
titre
—
9
27
158
1112
1.45
4.56
1.1
1.2
168.30
136.42
u/ml
0.25
21
385
536
6329
0.81
4.56
3.7
3.8
0.00
0.15
estimate
0.70
198
2105
280
3570
0.76
4.53
1.3
1.3
42.63
13.21
u/ml
0.86
82
1251
54
295
1.85
4.34
1.2
1.3
270.47
274.73
mosm/kgh2o
0.89
45
210
141
982
1.46
4.32
1.7
1.8
37.27
38.58
u/l
0.35
122
834
179
2414
0.72
4.24
2.2
2.2
178.58
162.89
ug/g
0.18
148
1903
41
207
2.00
4.17
1.1
1.2
—
—
—
0
0
31
141
2.21
4.11
1.9
1.9
—
—
—
0
0
372
3033
1.26
4.06
3.3
3.5
5.83
5.82
kpa
0.04
362
2954
249
3173
0.76
4.01
3.6
5.4
31.97
33.24
%
1.10
158
1990
92
597
1.56
3.96
1.5
1.9
12.51
12.61
mg/l
0.04
87
543
533
4552
1.21
3.78
2.3
2.7
2.17
2.25
g/l
2.25
504
4198
341
2778
1.26
3.75
4.8
7.0
9.26
11.14
mmol/l
5.75
325
2648
73
1138
0.63
3.73
1.9
2.1
3.31
3.42
ratio
0.34
60
947
1030
9331
1.17
3.68
3.2
3.4
1322.67
1721.57
ng/l
3.37
947
8187
560
4833
1.20
3.54
2.4
2.7
10.81
12.21
umol/l
3.84
534
4499
21
87
2.42
3.47
1.2
2.2
7685.40
36867.08
u/ml
—
5
13
46
783
0.58
3.39
1.6
1.9
3.39
3.41
mmol/l
0.03
33
594
440
5151
0.83
3.33
1.8
1.8
1037.68
1174.17
nmol/l
2.22
316
3835
29
142
2.05
3.26
1.6
1.5
4.63
6.72
u/l
0.52
23
116
160
1202
1.35
3.24
3.7
3.4
4.23
4.36
pmol/l
0.97
152
1048
11
307
0.36
3.19
1.3
1.5
—
—
—
0
0
26
125
2.09
3.08
1.3
1.3
—
—
—
0
0
26
125
2.09
3.08
1.3
1.3
—
—
—
0
0
30
153
1.97
3.04
1.4
2.0
—
—
—
0
0
56
880
0.63
3.02
1.1
1.0
—
—
—
0
0
21
437
0.48
3.01
1.4
1.4
—
—
—
0
0
21
94
2.24
2.96
1.1
1.1
—
—
—
0
0
62
399
1.57
2.86
1.8
2.5
145.00
1149.46
u/ml
—
8
35
93
653
1.44
2.84
1.4
1.5
115.16
12.40
iu/ml
0.42
25
122
344
4056
0.83
2.79
1.5
1.6
2.49
2.72
g/l
1.25
180
2348
696
6237
1.16
2.73
2.7
2.8
5.36
4.65
e6/l
0.76
632
5698
233
1894
1.25
2.66
6.4
6.7
25.16
24.43
mmol/l
2.69
220
1810
17
75
2.27
2.51
1.4
1.4
—
—
—
0
0
124
941
1.33
2.42
1.3
1.3
—
—
—
0
0
11
262
0.42
2.31
1.2
1.2
1.41
1.54
g/l
0.86
11
262
0
60
0.00
2.24
0.0
1.3
—
1.17
—
0
60
5
149
0.33
2.14
1.0
1.4
1.97
1.13
nmol/l
—
5
104
31
182
1.71
2.11
1.4
1.3
—
—
—
0
0
31
183
1.70
2.08
1.4
1.3
—
—
—
0
0
10
37
2.71
2.07
1.4
1.1
—
—
—
0
0
309
2664
1.18
1.99
2.2
2.2
0.20
0.20
g/l
0.29
284
2464
15
295
0.51
1.93
1.7
1.3
0.99
0.90
g/l
0.60
15
295
23
128
1.80
1.89
1.7
2.0
0.49
0.66
e9/l
0.93
23
119
199
2374
0.83
1.87
2.6
2.6
0.29
0.47
e6/l
1.58
194
2289
2091
21452
0.89
1.82
35.5
19.8
36.92
27.63
mg/l
26.02
2017
18214
121
958
1.28
1.81
1.8
2.5
0.00
0.00
g/l
-0.00
103
838
114
1438
0.78
1.80
2.5
2.5
19.73
19.50
au/ml
0.01
12
97
6
151
0.40
1.76
1.5
1.6
92.17
92.74
umol/l
—
6
151
84
636
1.33
1.75
1.5
1.5
0.23
0.24
g/l
0.16
75
608
21
117
1.80
1.74
1.0
1.0
—
—
—
0
0
81
611
1.34
1.73
1.4
2.5
28.90
33.92
umol/l
2.07
70
545
112
885
1.28
1.71
1.9
2.5
0.00
0.00
g/l
-0.00
103
837
43
291
1.49
1.70
1.1
1.2
0.18
0.19
nmol/l
0.21
29
239
289
2515
1.17
1.69
3.1
2.9
4.47
4.43
kpa
0.11
283
2445
8
31
2.59
1.66
2.4
1.5
—
—
—
0
0
29
181
1.61
1.63
2.5
2.9
28.14
29.42
mg/l
0.07
22
136
5
130
0.38
1.62
1.2
1.2
—
—
—
0
0
105
1306
0.80
1.51
1.3
1.3
67.01
57.03
au/ml
—
7
99
33
489
0.67
1.49
1.5
1.8
47.30
45.67
nmol/l
0.14
33
466
5
129
0.39
1.48
1.2
1.2
—
—
—
0
0
25
389
0.64
1.44
1.6
1.8
177.96
202.02
pmol/l
0.90
25
359
0
38
0.00
1.34
0.0
1.6
—
—
—
0
0
83
659
1.27
1.29
1.6
1.5
1.13
1.18
g/l
0.64
76
631
13
230
0.56
1.27
1.3
1.9
0.50
1.44
u/field
—
6
114
119
987
1.22
1.25
1.9
2.5
0.04
0.02
g/l
0.29
105
883
37
261
1.42
1.25
1.2
1.2
2.22
4.19
u/ml
—
9
88
16
92
1.74
1.25
2.5
2.2
0.62
0.61
mmol/l
0.31
16
92
56
424
1.33
1.24
1.3
1.2
—
—
—
0
0
17
278
0.61
1.24
1.5
1.5
—
—
—
0
0
13
70
1.86
1.24
1.2
1.6
90.08
568.87
nmol/24h
0.62
13
70
59
763
0.77
1.21
1.4
1.5
0.30
0.33
mg/l
0.15
26
334
1291
13420
0.93
1.19
5.4
3.4
68.42
57.39
u/l
2.12
1204
12308
6
127
0.47
1.16
1.0
1.7
36.28
39.38
g/l
—
6
127
1070
10216
1.08
1.15
4.8
4.4
30.57
72.86
ng/l
3.82
894
8142
47
615
0.76
1.08
1.6
1.6
—
—
—
0
0
278
2508
1.12
1.03
2.7
3.1
212.55
234.93
ng/l
0.34
254
2314
23
335
0.68
1.03
1.1
1.1
1.17
74.71
iu/ml
—
6
56
179
2026
0.88
0.97
5.1
2.9
61.87
59.70
ml/min/173m2
0.37
88
925
79
649
1.22
0.97
1.8
3.3
116.35
1071.94
u/ml
1.44
70
596
86
715
1.21
0.94
3.3
3.4
0.83
0.83
nmol/l
0.00
68
577
16
101
1.59
0.93
1.1
1.1
—
—
—
0
0
34
253
1.35
0.90
1.2
1.2
2.27
7.15
u/ml
1.76
11
117
22
313
0.70
0.89
1.7
1.5
60.18
61.95
%
0.09
17
191
11
182
0.60
0.89
1.1
1.8
65.73
123.36
ng/l
3.39
11
182
38
495
0.76
0.89
1.2
1.4
0.86
0.83
nmol/l
0.06
28
398
321
2947
1.10
0.88
2.5
2.6
72.26
68.35
e9/l
0.88
194
2191
8
42
1.91
0.88
1.0
1.3
—
—
—
0
0
13
79
1.65
0.88
1.2
1.2
209.73
240.91
iu/ml
0.12
13
79
167
1883
0.88
0.88
1.6
1.7
1.67
1.63
%
0.24
140
1564
64
781
0.82
0.87
1.5
1.5
—
—
—
0
0
23
161
1.43
0.86
1.2
1.2
—
—
—
0
0
43
546
0.78
0.84
1.2
1.4
—
—
—
0
0
28
205
1.37
0.83
3.0
2.1
7.87
8.27
mmol/l
0.28
28
205
43
337
1.28
0.81
3.4
2.4
1.20
1.19
mmol/l
0.38
43
332
18
122
1.48
0.80
4.0
6.6
249.44
29.06
ug/l
0.42
12
75
23
164
1.41
0.79
1.2
1.2
—
—
—
0
0
36
277
1.30
0.79
2.9
2.6
—
—
—
0
0
5
99
0.50
0.77
1.0
1.3
118.42
146.91
pmol/l
—
5
99
0
27
0.00
0.77
0.0
1.1
—
—
—
0
0
5
24
2.09
0.74
1.0
1.0
14.60
37.44
iu/ml
—
5
24
62
741
0.83
0.72
1.3
1.4
—
—
—
0
0
132
1171
1.13
0.70
1.9
2.5
10.84
10.42
g/l
0.41
117
1043
23
169
1.36
0.69
1.2
1.1
—
—
—
0
0
23
169
1.36
0.69
1.2
1.1
—
—
—
0
0
43
346
1.25
0.69
3.4
2.4
105.00
105.37
mmol/l
0.17
43
341
43
346
1.25
0.69
3.4
2.4
4.15
4.11
mmol/l
0.26
43
341
31
239
1.30
0.69
1.1
1.1
—
—
—
0
0
7
121
0.58
0.67
1.1
1.1
—
—
—
0
0
5
28
1.79
0.66
1.0
1.3
—
—
—
0
0
18
128
1.41
0.65
1.3
1.2
—
—
—
0
0
85
736
1.16
0.65
2.9
2.8
1.59
1.76
mg/l
1.20
80
654
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
17
120
1.42
0.64
1.1
1.1
—
—
—
0
0
5
29
1.73
0.64
1.6
1.8
—
—
—
0
0
59
698
0.84
0.63
1.4
1.6
29256.62
13963.31
e6/l
0.83
40
481
23
172
1.34
0.63
3.4
5.5
16.32
27.31
u/ml
—
6
51
29
370
0.78
0.63
2.4
2.3
31.25
21.59
mg/l
0.32
12
116
6
102
0.59
0.62
1.3
1.3
6.35
6.23
mmol/l
—
6
97
155
1403
1.11
0.61
5.4
5.0
1.71
1.56
%
0.90
145
1324
129
1156
1.12
0.61
2.6
3.6
36.65
69.12
mg/l
1.50
104
984
0
20
0.00
0.60
0.0
1.0
—
—
—
0
0
0
20
0.00
0.60
0.0
1.0
—
0.14
—
0
9
129
1158
1.12
0.59
2.6
3.6
42.95
56.30
mg/l
1.26
101
982
69
593
1.17
0.59
1.1
1.2
—
—
—
0
0
130
1168
1.12
0.59
2.0
2.6
1.33
1.15
g/l
0.15
109
993
117
1046
1.12
0.58
2.7
3.4
1.69
3.43
ratio
1.99
61
616
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
18
134
1.35
0.53
1.6
3.4
1.56
1.12
%
0.38
18
134
51
598
0.85
0.52
1.3
1.5
—
—
—
0
0
41
341
1.21
0.52
1.2
1.3
138.85
159.43
au/ml
0.42
12
97
69
601
1.15
0.52
1.1
1.2
—
—
—
0
0
141
1286
1.10
0.51
5.7
5.2
0.85
0.86
%
0.15
131
1212
49
416
1.18
0.51
4.3
6.5
11.27
12.48
mg/l
1.15
44
390
13
92
1.42
0.50
1.2
1.2
0.56
0.48
ratio
—
6
54
37
306
1.21
0.50
1.3
1.4
—
—
—
0
0
37
306
1.21
0.50
1.4
1.4
—
—
—
0
0
20
258
0.77
0.50
1.2
1.3
446827.54
143944.66
e6/l
0.36
13
177
43
509
0.84
0.50
1.1
1.2
—
—
—
0
0
23
180
1.28
0.49
1.2
1.1
—
—
—
0
0
25
198
1.27
0.49
1.2
1.2
—
—
—
0
0
28
225
1.25
0.49
2.0
2.2
632.16
644.54
ml
0.04
19
139
7
109
0.64
0.48
3.1
4.0
13.83
13.46
%
—
7
109
37
308
1.20
0.48
1.4
1.4
—
—
—
0
0
14
102
1.37
0.47
1.1
1.0
1.16
1.27
u/l
—
8
49
7
49
1.43
0.46
5.9
2.6
16.43
14.92
ml/dl
—
7
44
7
49
1.43
0.46
1.0
1.3
—
—
—
0
0
8
119
0.67
0.45
1.6
1.8
13.75
15.94
nmol/l
—
8
108
1621
15957
1.04
0.45
5.0
5.3
474.18
2271.04
e6/l
1.86
22
259
21
165
1.27
0.45
1.5
2.0
—
—
—
0
0
604
6249
0.96
0.43
3.0
3.3
0.08
0.04
0.18
12
202
67
754
0.89
0.42
1.6
1.6
29.98
25.53
u/ml
0.19
13
122
50
434
1.15
0.42
2.5
2.1
31.98
32.53
pg
0.38
50
429
49
563
0.87
0.42
4.2
3.6
32.42
30.00
mg/l
0.14
36
396
70
623
1.13
0.41
6.5
6.8
103.58
105.36
mmol/l
2.08
57
552
35
295
1.19
0.41
1.2
1.4
—
—
—
0
0
8
58
1.38
0.41
1.3
1.3
36.00
11.43
mm/h
—
8
58
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
0
17
0.00
0.40
0.0
1.2
—
6.29
—
0
17
196
1838
1.07
0.40
2.2
2.9
10.04
10.73
g/l
1.35
182
1678
0
18
0.00
0.40
0.0
1.4
—
—
—
0
0
11
149
0.74
0.40
1.3
1.2
7.36
10.27
mmol/l
4.36
11
138
242
2553
0.94
0.37
2.2
2.5
4.41
7.64
ug/l
5.23
212
2226
10
72
1.39
0.37
1.0
1.1
27.62
19.08
u/ml
—
5
23
1685
17059
0.97
0.36
42.4
24.7
14.47
13.90
%
45.71
1673
16808
135
1256
1.08
0.35
1.9
2.5
3.39
2.97
g/l
4.80
122
1136
5
76
0.66
0.35
1.2
1.1
—
—
—
0
0
144
1344
1.08
0.35
1.8
2.5
4.13
4.16
g/l
0.24
131
1225
6
86
0.70
0.33
1.0
1.0
—
—
—
0
0
6
86
0.70
0.33
1.0
1.1
—
—
—
0
0
710
7274
0.97
0.31
2.3
2.4
3.06
2.93
mg/l
0.64
609
6229
143
1343
1.07
0.31
1.8
2.5
3.86
3.76
g/l
0.25
129
1224
143
1344
1.07
0.30
1.8
2.5
8.00
7.43
g/l
2.96
129
1224
61
672
0.91
0.30
2.4
2.3
86.05
94.68
ug/min
0.14
37
396
1726
17080
1.03
0.30
5.3
4.6
20.13
14.24
mm/h
25.87
1639
15805
40
451
0.89
0.29
1.2
1.2
71.71
50.58
u/ml
—
7
54
72
785
0.91
0.29
1.4
1.5
282.47
266.27
ug/g
0.22
46
492
8
107
0.75
0.29
1.0
1.2
—
66.00
%
—
0
16
65
594
1.10
0.28
1.2
1.2
—
0.62
—
0
5
5
75
0.67
0.25
1.0
1.1
—
—
—
0
0
13
105
1.24
0.24
1.0
1.1
6.32
12.23
iu/ml
—
5
28
9
76
1.18
0.24
1.2
1.1
—
—
—
0
0
19
223
0.85
0.24
1.4
1.4
—
1240.00
—
0
6
16
133
1.20
0.24
1.1
1.1
—
—
—
0
0
17
201
0.84
0.23
1.2
1.5
—
—
—
0
0
46
505
0.91
0.23
1.3
1.4
537.30
827.90
e6/l
0.29
30
406
16
134
1.20
0.23
1.1
1.4
21.22
5.90
u/l
0.62
11
117
14
168
0.83
0.22
1.1
1.5
—
—
—
0
0
36
323
1.12
0.22
1.4
1.4
—
—
—
0
0
7
93
0.75
0.22
1.0
1.4
27.29
29.48
umol/l
—
7
85
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.2
—
7.76
—
0
11
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
1.23
—
0
5
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
209
2169
0.96
0.21
2.7
3.9
86.79
96.42
ng/l
0.95
187
1844
148
1547
0.95
0.20
2.9
2.5
0.62
0.61
%
0.14
148
1538
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
0
14
0.00
0.20
0.0
4.1
—
—
—
0
0
13
155
0.84
0.20
2.1
2.4
—
—
—
0
0
36
326
1.11
0.20
1.4
1.4
—
—
—
0
0
46
500
0.92
0.20
1.2
1.3
6.53
42.06
e6/l
1.40
30
379
181
1880
0.96
0.19
3.6
3.0
124.14
127.46
g/l
1.30
175
1822
12
100
1.20
0.18
1.6
2.6
4.46
4.87
kpa
0.99
12
100
12
100
1.20
0.18
1.6
2.6
9.51
9.95
kpa
0.32
12
100
25
223
1.12
0.18
1.0
1.1
—
68.29
—
0
7
5
70
0.71
0.16
1.0
1.1
—
—
—
0
0
114
1190
0.96
0.16
1.3
1.3
241.99
237.02
u/ml
0.02
102
1092
35
321
1.09
0.16
1.4
1.4
—
—
—
0
0
18
158
1.14
0.16
2.2
1.4
—
—
—
0
0
18
158
1.14
0.16
2.2
1.4
—
—
—
0
0
8
71
1.13
0.16
1.0
1.1
—
—
—
0
0
77
731
1.05
0.15
1.4
1.3
—
—
—
0
0
48
449
1.07
0.15
1.3
1.3
—
—
—
0
0
14
122
1.15
0.13
1.1
1.3
—
—
—
0
0
8
97
0.82
0.13
1.1
1.2
—
—
—
0
0
216
2215
0.97
0.13
1.2
1.3
—
—
—
0
0
20
180
1.11
0.13
1.0
1.1
—
—
—
0
0
75
784
0.96
0.12
1.1
1.3
—
—
—
0
0
40
377
1.06
0.11
1.4
1.6
167.28
290.12
pmol/l
0.94
40
370
289
2840
1.02
0.10
5.0
3.8
—
—
—
0
0
137
1407
0.97
0.10
4.0
3.6
1.02
1.02
ratio
0.37
122
1291
5
46
1.09
0.09
1.2
1.3
—
—
—
0
0
19
174
1.09
0.09
1.2
1.1
—
—
—
0
0
81
784
1.03
0.08
1.2
1.2
0.40
1.51
u/ml
—
5
55
16
175
0.91
0.08
1.0
1.1
—
—
—
0
0
6
58
1.03
0.08
1.0
1.0
—
—
—
0
0
6
58
1.03
0.08
1.5
2.1
174.33
212.48
%
—
6
52
5
64
0.78
0.08
1.0
1.1
—
—
—
0
0
5
64
0.78
0.08
2.0
1.5
0.26
0.37
ug/l
—
5
42
1043
10491
0.99
0.08
2.6
2.3
—
—
—
0
0
29
307
0.94
0.07
1.0
1.0
—
—
—
0
0
150
1471
1.02
0.07
2.0
2.0
2.02
1.45
g/l
0.78
139
1328
187
1901
0.98
0.07
1.9
2.2
9.05
12.57
nmol/l
6.32
154
1660
13
118
1.10
0.07
1.0
1.1
—
—
—
0
0
8
92
0.87
0.06
1.1
1.3
—
—
—
0
0
12
132
0.91
0.06
1.1
1.1
—
82.56
—
0
9
157
1549
1.01
0.04
1.8
1.7
1.83
1.53
g/l
2.69
138
1335
21
199
1.06
0.04
1.3
1.2
110.00
98.79
pmol/l
0.56
21
199
31
322
0.96
0.04
1.2
1.2
263.50
296.78
u/ml
0.36
18
174
67
656
1.02
0.04
1.2
1.2
22.20
32.00
u/ml
—
5
36
25
240
1.04
0.03
1.6
1.7
3.84
4.60
mg/l
0.69
25
231
27
261
1.03
0.02
1.1
1.1
18.81
21.67
au/ml
—
7
36
24
248
0.97
0.02
1.0
1.3
—
—
—
0
0
10
94
1.06
0.01
1.1
1.2
—
—
—
0
0
90
895
1.01
0.00
1.5
1.6
8.93
6.96
iu/ml
0.32
20
210
63
631
1.00
0.00
1.1
1.2
2.83
3.15
u/ml
—
6
65
12
116
1.03
0.00
1.1
1.1
—
—
—
0
0
43
427
1.01
0.00
1.6
1.9
4.79
4.63
mmol/24h
0.11
36
367
50
503
0.99
0.00
1.2
1.3
—
238.57
—
0
14
63
633
1.00
0.00
1.2
1.3
8.33
6.23
u/ml
—
9
101
15
153
0.98
0.00
1.3
1.3
0.16
2.09
u/ml
—
10
89
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
48.92
—
0
5
0
6
0.00
-0.00
0.0
4.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
5.2
—
386.50
—
0
6
0
5
0.00
-0.00
0.0
5.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
6.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
0.01
—
0
7
0
6
0.00
-0.00
0.0
1.2
—
1.10
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
9
95
0.95
-0.00
1.2
1.6
188.78
283.65
mu/l
—
9
72
6
63
0.95
-0.00
1.0
1.5
—
—
—
0
0
6
67
0.90
-0.00
1.2
2.6
6.17
514.51
ug/l
—
6
67
5
56
0.89
-0.00
1.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: HLP_C3_NSCLC_ADENO – Non-small cell lung cancer, adenocarcinoma, helper endpoint
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).